Novavax Plays Down EU COVID Vaccine Contract Delay

Manufacturing Issues Not To Blame

 
• By Andrew McConaghie

Investors are anxious about the delay to Novavax’s deal with the EU, and want to know how and when it might file the vaccine with regulators.

Brussels Flags Mask
Novavax is still engaged in negotiations with the European Commission - who will want to avoid further manufacturing delays as seen with AstraZeneca.

More from Business

More from Scrip